KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Pacira BioSciences (PCRX) over the last 16 years, with Q3 2025 value amounting to $734.8 million.

  • Pacira BioSciences' Non-Current Assets fell 1165.0% to $734.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year decrease of 1997.91%. This contributed to the annual value of $808.4 million for FY2024, which is 2405.19% down from last year.
  • As of Q3 2025, Pacira BioSciences' Non-Current Assets stood at $734.8 million, which was down 1165.0% from $791.6 million recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Non-Current Assets peaked at $1.2 billion during Q1 2022, and registered a low of $533.3 million during Q2 2021.
  • Its 5-year average for Non-Current Assets is $953.7 million, with a median of $1.0 billion in 2024.
  • In the last 5 years, Pacira BioSciences' Non-Current Assets skyrocketed by 12649.21% in 2022 and then crashed by 2405.19% in 2024.
  • Pacira BioSciences' Non-Current Assets (Quarter) stood at $1.2 billion in 2021, then dropped by 2.19% to $1.2 billion in 2022, then dropped by 10.02% to $1.1 billion in 2023, then fell by 24.05% to $808.4 million in 2024, then decreased by 9.1% to $734.8 million in 2025.
  • Its Non-Current Assets stands at $734.8 million for Q3 2025, versus $791.6 million for Q2 2025 and $826.7 million for Q1 2025.